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Abstract 
We have previously reported a synthetic Laponite® crosslinked pNIPAM-co-DMAc 
(NPgel) hydrogel, which induces nucleus pulposus (NP) cell differentiation of human 
MSCs (hMSCs) without the need for additional growth factors. Furthermore NP gel 
supports integration following injection into the disc and restores mechanical function 
to the disc. However, translation of this treatment strategy into clinical application is 
dependent on the survival and differentiation of hMSC to the correct cell phenotype 
within the degenerate IVD. Here, we investigated the viability and differentiation of 
hMSCs within NP gel within a catabolic microenvironment.  
Human MSCs were encapsulated in NPgel and cultured for 4 weeks under hypoxia 
(5% O2) with ± calcium, IL-1β and TNFα either individually or in combination to mimic 
the degenerate environment. Cell viability, and cellular phenotype was investigated. 
Stem cell viability was maintained within hydrogel systems for the 4 weeks 
investigated under all degenerate conditions. NP matrix markers: Agg and Col II and 
NP phenotypic markers: HIF-1α, FOXF1 and PAX1 were expressed within the NPgel 
cultures and expression was not affected by culture within degenerate conditions. 
Alizarin red staining demonstrated increased calcium deposition under cultures 
containing CaCl2 indicating calcification of the matrix. Interestingly MMP's, ADAMTS 
4 and Col I expression by hMSCs cultured in NPgel was upregulated by calcium but 
not by pro-inflammatory cytokines IL-1β and TNFα. 
Importantly IL-1β and TNFα, regarded as key contributors to disc degeneration, were 
not shown to affect the NP cell differentiation of MSCs in the NPgel. In agreement 
with our previous findings, NPgel alone was sufficient to induce NP cell 
differentiation of MSCs, with expression of both aggrecan and collagen type II, under 
both standard and degenerate culture conditions; thus could provide a therapeutic 
option for the repair of the NP during IVD degeneration.   
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Introduction 
Low back pain (LBP) is a common debilitating clinical condition that affects 80% of 
the population at some point during their lifetime1. Although the aetiology remains 
unclear, it is widely accepted that intervertebral disc (IVD) degeneration is a major 
cause of LBP2. Morphologically the IVD is composed of three distinct regional 
structures: the cartilaginous endplates (CEP); the annulus fibrosus (AF), and the 
central gelatinous nucleus pulposus (NP). The nucleus pulposus is rich in 
proteoglycans (mainly aggrecan) and collagen type II3-5. The IVD functions to 
separate the vertebrae and facilitate a range of spinal movements6. 
Degeneration of the IVD is characterised by a loss of matrix due to altered cellular 
metabolism and an imbalance between matrix synthesis and matrix breakdown7, 8. 
As IVD degeneration advances, collagen type II in the NP is gradually replaced by 
the more fibrous collagen type I4. In addition, overall proteoglycan composition is 
altered by a reduction in synthesis of aggrecan9, 10, reducing the water binding 
capacity, which results in a condensed and more fibrous NP9, 10. Furthermore, matrix 
degradation is accelerated by upregulation of matrix degrading enzymes, matrix 
metalloproteinases (MMPs) and a disintegrin and metalloproteinase with 
thrombospondin motifs (ADAMTS)11-13. These changes in the matrix are also 
accompanied by cellular changes with increased apoptosis14 and senescence 
displayed by NP cells15-18. Collectively, these events result in a loss in the structural 
integrity of the NP and overall reduced disc height decreasing the capacity to 
withstand load. The subsequent asymmetric distribution of load on degraded regions 
leads to the formation of tears and fissures through the AF region of the disc19, 20. 
These fissures can lead to disc herniation and enable the ingrowth of nerves and 
A
cc
ep
te
d 
A
rti
cl
e
This article is protected by copyright. All rights reserved.
4 
 
blood vessels21 22, which are associated with the sensation of chronic low back 
pain22-27. 
The mechanisms behind IVD degeneration are attributed to an imbalance between 
anabolic and catabolic processes7. Inflammatory cytokines, particularly interleukin-1β 
(IL-1β) and tumour necrosis factor alpha (TNFα) are increased during disc 
degeneration, and have been implicated as key factors in the pathogenesis of disc 
degeneration28-35. Calcification of the IVD is also commonly present in ageing and 
end stage degeneration36, thus is considered to cause, or at least promote the 
process of IVD degeneration36, 37. It has been suggested that calcification of the 
cartilaginous endplate leads to disc degeneration by acting as a barrier to nutrient 
transport and decreasing nutrient availability in the disc38-40. Recent studies indicate 
that increased extracellular calcium may play a role in disc degeneration by 
activating the extracellular calcium-sensing receptor CaSR, leading to increased 
ADAMTS activity36. Ultimately, the mechanisms responsible for the calcification of 
the disc are unclear and, currently there is no scientific consensus on whether 
calcification causes disc degeneration by altering the disc metabolism, or whether 
degenerative changes in the IVD alters its properties and leads to mineral 
deposition39. For example the increased expression of collagen type I during disc 
degeneration could provide nucleation sites for mineral deposition41, 42.   
Current treatments for LBP, attributed to intervertebral disc (IVD) degeneration, fail 
to address the underlying tissue pathology7. However, emerging treatments are 
aimed at developing a biological approach to overcome this7,43. From a clinical 
perspective, the aim is to restore/maintain spine biomechanics and alleviate patient 
symptoms7. Subsequently, a tissue engineering approach with the use of cells in 
combination with a biomaterial scaffold, to regenerate the matrix while restoring disc 
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height, remains an attractive strategy43. We have previously reported a synthetic 
Laponite® crosslinked poly N-isopropylacrylamide-co- N, N' -dimethylacrylamide 
(NPgel) hydrogel, which induces nucleus pulposus (NP) cell differentiation of human 
MSCs (hMSCs). With expression of NP phenotypic markers and matrix deposition 
that mimics that of native NP tissue, without the use of chondrogenic inducing 
medium or additional growth factors44,45. Furthermore NPgel can be injected into 
native disc tissue with a small bore needle (26G), where it supports integration and 
restores mechanical function to the disc44,45. However, these studies were performed 
in the absence of factors observed within the degenerate disc. The clinical success 
of this hydrogel is dependent on the capacity to support the survival and 
differentiation of incorporated hMSCs into the correct NP cell phenotype within a 
catabolic environment such as that associated with disc degeneration.  
As such, we investigated the efficacy of hMSCs incorporated into NPgel under 
conditions that mimic the cytokine and Ca2+ rich environment associated with the 
degenerate microenvironment. Specifically this study investigated the effects of IL-1β, 
TNFα and Ca2+ on hMSC survival and differentiation within the L-pNIPAM-co-DMAc 
hydrogel together with the influence on production of matrix degrading enzymes.  
Methods 
Hydrogel Synthesis 
Laponite® crosslinked pNIPAM-co-DMAc (NPgel) hydrogel was prepared as 
previously described45. Briefly a 10ml exfoliated suspension of 0.1g Laponite® clay 
nanoparticles (25-30nm diameter, <1nm thickness) (BYK Additives Ltd, Cheshire 
UK) in 18 mΩ deionised H20 was prepared. To 10ml exfoliated clay suspension 
0.773g N-isopropylacrylamide 99% (NIPAM) (Sigma, Poole UK); 0.117g N, N' -
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dimethylacrylamide (DMAc) (Sigma, Gillingham UK) and 0.01g 2-2'-
azobisisobutyronitrile (AIBN)(Sigma, Poole UK) were added, mixed well and strained 
through 5-8µm pore filter paper, polymerisation was performed at 80ºC for 24h. 
Hydrogel suspension was cooled to 38-39oC prior to cell incorporation.  
Expansion and incorporation of human mesenchymal stem cells in 
hydrogels 
Commercial bone marrow derived human adult mesenchymal stem cells (hMSCs) 
extracted from a 42 yr old donor (Lonza, Slough UK) were cultured in DMEM media 
(Life Technologies, Paisley UK) supplemented with 10% v/v heat inactivated foetal 
calf serum (FCS) (Life Technologies, Paisley UK), 100U/ml Penicillin (Life 
Technologies Paisley UK), 100 μg/ml Streptomycin (Life Technologies Paisley UK), 
250 ng/ml amphotericin (Sigma, Poole UK), 2 mM glutamine (Life Technologies, 
Paisley UK) and 10 μg/ml ascorbic acid (Sigma, Poole UK) (complete cell culture 
media). Following expansion in monolayer to passage 7, 1x106 cells/ml cells were 
mixed with the hydrogel suspension at 38 to 39°C and 300 μL added into the centre 
wells of a sterile 48 well culture plate leaving the outer wells void of hydrogel, 
acellular controls were also established as described previously45. All acellular and 
hMSC hydrogel scaffolds were cultured in 1ml complete cell culture media in addition 
to known catabolic factors; ± calcium (2.5mM and 5.0mM CaCl2), 10ng/ml IL-1β and 
10ng/ml TNFα either individually or in combination to mimic the degenerate 
microenvironment and incubated at 37 °C, 5% CO2 and maintained in culture for up 
to 4 weeks in an oxygen controlled glove box (Coy Lab products, York, UK) at 5% O2. 
Complete culture media was replaced every 2–3 days with application of fresh 
cytokines and CaCl2. Samples were removed for the initial 7 days for analysis of 
metabolic cell activity, and following 4 weeks for histological assessment of matrix 
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deposition and hMSC differentiation and matrix degrading enzyme production using 
immunohistochemistry (IHC).   
Cytocompatibility of hMSC cultured in presence of cytokines and Ca2+ 
The metabolic cell activity of hMSCs incorporated in solidified pNIPAM-DMAc-
Laponite® hydrogels, cultured in 5% O2 at a density of 1×10
6 cells/ml were assessed 
using Alamar Blue assay (Life Technologies, Paisley UK) using the manufacturers 
protocol following 7 days within the different culture conditions. The absorbance was 
recorded using a fluorescence microplate reader (CLARIOstar®, BMG LABTECH) at 
a fluorescence excitation wavelength of 590nm. Relative fluorescence units (RFU) 
were recorded for cellular hydrogel scaffolds and normalised to the RFU of acellular 
control scaffolds as an indication of cytotoxicity/proliferation. 
Histological analysis 
Matrix deposition was investigated in hydrogels cultured with or without cells under 
the varied culture conditions following 4 weeks. Triplicate samples were removed 
from culture and fixed, processed to wax and 4μm sections prepared for histological 
and immunohistochemical analysis as described previoulsy45. Sections were 
assessed using histological stains: H&E, Alizarin red, Alcian blue and Masson's 
trichrome as described previously45. All slides were examined with an Olympus BX51 
microscope and images captured by digital camera and Capture Pro OEM v8.0 
software (Media Cybernetics, Buckinghamshire, UK). Histological sections were 
analysed, and images captured to document their histological appearance and 
cellular staining patterns. Calcium deposition was measured as a percentage 
staining area using ImageJ 1.5i software. The whole field of view was used as the 
area of interest. The image was split into red, green and blue using RGB stacks and 
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the threshold was applied at a range of 0-147 using the blue channel which gave the 
best contrast for red (calcium) staining; the percentage area of the red staining was 
then measured. 
Immunohistochemical analysis 
IHC was performed on hMSCs taken from monolayer culture prior to hydrogel 
encapsulation to serve as time zero controls. Cytospins were formed as described 
previously45. Caspase 3 was utilised as a marker of apoptosis for 
immunohistochemistry (IHC) investigation as an indication of cell viability of hydrogel 
encapsulated hMSCs under the different culture conditions. NP matrix markers: 
aggrecan, collagen type II, chondroitin sulphate and NP phenotypic markers: HIF1α, 
PAX1, FOXF146 together with NP negative markers: collagen type I and osteopontin 
were selected for immunohistochemistry investigation to assess differentiation 
capacity of hMSCs within monolayer culture and following culture within NPgel under 
the different culture conditions. To determine the influence of culture conditions on 
MSCs cultured within NPgel on the production of matrix degrading enzymes, 
immunohistochemistry for MMP3, MMP13 and ADAMTS 4 were investigated. 
Immunohistochemical analysis for the catabolic cytokine IL-1β and its receptor IL-1RI 
were investigated to determine the influence of NPgel culture and whether a 
catabolic phenotype was induced within hMSCs cultured in presence of cytokines 
and Ca2+. IHC was performed as previously described33,45 specific antibody details 
provided in  (Table 1). Briefly, 4 μm paraffin sections were de-waxed, rehydrated and 
endogenous peroxidase-blocked with hydrogen peroxide (Sigma, Aldrich Poole UK). 
Following washes in tris-buffered saline (TBS; 20 mM tris, 150 mM sodium chloride, 
pH 7.5) sections were subjected to antigen retrieval methods where required (Table 
1). Following TBS washing, nonspecific binding sites were blocked at room 
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temperature for 90 min with 25% w/v serum (Abcam, Cambridge, UK) (Table 1) in 
1% w/v bovine serum albumin in TBS. Sections were incubated overnight at 4 °C 
with primary antibodies (Table 1), or mouse or rabbit IgG controls (Abcam 
Cambridge UK). Sections were washed in TBS and incubated with 1:500 biotinylated 
secondary antibody (Table 1), washed and incubated in HRP-streptavidin biotin 
complex (Vector Laboratories, Peterborough, UK). Sections were washed again in 
TBS prior to 20 minute incubation in 0.65 mg/mL 3,3-diaminobenzidine 
tetrahydrochloride 0.08% v/v hydrogen peroxide (Sigma Aldrich, Poole UK) in TBS. 
Sections were counterstained with Mayer’s Haematoxylin (Leica Microsystems, 
Milton Keynes UK), dehydrated in IMS (Fisher, Loughborough UK), cleared in SubX 
(Leica Microsystems, Milton Keynes UK) and mounted in Pertex (Leica 
Microsystems, Milton Keynes UK). All slides were visualised using an Olympus BX51 
microscope and images captured by digital camera and Capture Pro OEM v8.0 
software (Media Cybernetics, Buckinghamshire, UK). IHC staining was evaluated by 
counting total immunopositive and immunonegative cells for each section and 
immunopositive cells expressed as a percentage of total count. 
Data Processing and Statistical Analysis 
All tests were performed at least in triplicate. Data was non-parametric and hence 
statistical comparisons were performed by Kruskal-Wallis with pairwise comparisons 
(Conover-Inman), statistical significance was accepted at p≤0.05. 
Results 
Cytocompatibility of hMSCs in the presence of cytokines and free Ca2+ 
Alamar blue assay, as a measure cell viabilty was utilised, metabolic cell activity was 
assessed over 7 days in culture in NPgel under non degenerate control conditions 
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and in the presence of cytokines and Ca2+. No significant difference in metabolic cell 
activity was detected over the 7 day culture period where hMSCs were incorporated 
into NPgel constructs cultured in any of the experimental conditions (data not shown).  
Low levels of apoptosis were observed in MSCs cultured in NPgels under non-
degenerate standard conditions and the standard culture experimental groups 
treated with cytokines IL-1 and TNF alone, with no significant difference in the 
number of caspase 3 immunopositive cells throughout the 4 week culture duration 
(Fig. 1). Where IL-1and TNFwere used in combination there was a significant 
increase in the number of immunopositive cells compared to the non-degenerate 
standard control (P=0.0404) (Fig. 1). A significant difference in the number of 
caspase 3 immunopositive cells was observed between the standard non-
degenerate conditions and each of the experimental groups cultured with CaCl2 
(2.5mM CaCl2 v/s standard culture P=0.0003; 5mM CaCl2 v/s standard culture 
P=0.0021)(Fig. 1). Whilst co-treatment with 2.5mM CaCl2 with IL-1 showed 
significantly fewer caspase 3 positive cells than treatment with 2.5mM CaCl2 alone 
(P=0.0023)(Fig. 1), as did co-treatment of 5mM CaCl2 with TNFcompared to 
treatment with 5mM CaCl2 alone (P=0.0457)(Fig. 1). Although no culture condition 
showed greater than 30% caspase 3 positive cells within NPgel cultures indicating 
changes were relatively small (Fig.1) 
Histological and immunohistochemical evaluation of matrix components 
in hMSCs in the presence of cytokines and free Ca2+ 
Proteoglycan deposition was observed by alcian blue staining within hydrogels 
encapsulated with hMSCs (Fig. 2), whilst some background staining was observed in 
no cell control hydrogels increeased staining was observed in those hydrogels 
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containing cells (Fig. 2). Monolayer hMSCs extracted from culture prior to hydrogel 
encapsulation showed no immunopositivity for aggrecan (Fig. 2&3). Whilst cellular 
immunopositivity for aggrecan was significantly increased in hMSC cells cultured in 
NPgel under non-degenerate standard culture conditions in comparison to the 
monolayer controls (P=0.0112)(Fig. 2&3). No difference in immunopositivity was 
observed between the non-degenerate standard culture conditions and culture with 
cytokines and free Ca2+ (Fig. 2&3). Collagen deposition was observed, by Masson's 
trichrome staining and immuohistochemical detection of collagen type II and collagen 
type I (Fig. 2). Monolayer hMSCs extracted from culture prior to hydrogel 
encapsulation showed low levels of immunopositivity for collagen type II and 
collagen type I (Fig. 2 &3). An increase in cellular immunopositivity for collagen type 
II was observed in hMSC scaffolds under non-degenerate standard control 
conditions in comparison to monolayer controls (P=0.0002)(Fig. 3). A significant 
decrease in the percentage of immunopositive cells for collgen type II was observed 
in the cultures with 5mM CaCl2 alone (P=0.0007) however this decrease was 
significantly reduced with co-treatment with either IL-1 or TNF in combination with 
5mM CaCl2 (IL-1 P=0.0141, TNFP=0.0107) (Fig. 3). No difference was observed 
in cellular immunopositivity for collagen type I in hMSC scaffolds cultured under non-
degenerate control conditions in comparison to monolayer controls. A significant 
increase in the percentage of immunopositive cells for collagen type I was observed 
in all the cultures containing 2.5mM CaCl2 and 5mM CaCl2 (2.5mM CaCl2 P=0.0034 
and 5mM CaCl2P=0.0062) (Fig. 3) with no difference seen following stimulation with 
cytokines (Fig.3).  
Calcium deposition as confirmed by Alizarin red staining (Fig. 4), was observed in 
hMSC cultured in NPgel under standard culture conditions and those contining non-
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degenerate and degenerate conditions. A significant increase in the percentage 
staining of calcium deposition was observed in experimental groups cultured in 
media supplemented with 2.5mM CaCl2 (P=0.0009) and 5mM CaCl2 (P<0.0001) 
compared to non-degenerate standard media controls, with a dose dependant effect 
seen (P=0.0068) (Fig. 4). Calcium deposition was also significantly increased 
compared to the CaCl2 treated no cell controls following 5mM CaCl2 (P=0.0034) (Fig. 
4). Although hydrogels containing cells showed significantly higher calcium 
deposition than no cell controls following treatment with CaCl2 (2.5mM P<0.0001; 
5mM P<0.0001)(Fig. 4). 
Immunohistochemical evaluation of NP cell phenotypic markers in the 
presence of cytokines and free Ca2+ 
NP phenotypic markers FOXF1, PAX1, HIF1α were identified using IHC under non-
degenerate standard control conditions and in the presence of cytokines and free 
Ca2+ to assess the ability of encapsulated hMSCs to maintain differentiation into NP-
like cells within catabolic conditions seen in the degenerate microenvironment (Fig. 
5). FOXF1 was seen at high levels within monolayer culture, which was maintained 
within the NPgel cultures in standard culture (Fig. 5). The percentage of cells 
immunopositive for FOXF1 was not affected by culture with CaCl2 alone, however 
culture with IL-1 and/or TNF in combination with 5mM CaCl2 significantly 
decreased FOXF1 expression compared to 5mM CaCl2 alone (5mM CaCl2 + IL-1 P 
= 0.01; 5mM CaCl2 +TNFP= 0.0351; 5mM CaCl2 + IL-1+ TNFP =0.0106) (Fig 
5). PAX1 expression was also already expressed highly by monolayer MSCs and 
was not significantly altered in NPgel cultures under standard culture conditions. The 
percentage of cells immunopositive for PAX1 was not affected by culture with CaCl2 
alone (Fig. 5). The cellular immunopositivity for PAX1 was significantly increased in 
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the groups cultured in standard media with TNF compared to standard culture 
alone (P=0.0139) (Fig. 5). Few MSCs in monolayer showed immunopositivity for 
HIF1α, which was increased in NPgel cultures (Fig. 5). The number of cells with 
immunopositivity for HIF1α was increased in standard media with addition of IL-1 
and TNF in combination (P=0.0493)(Fig.5). HIF1α was also increased following 
culture of MSCs in NPgel cultured in 5mM CaCl2 compared to standard culture 
(P=0.0015) (Fig. 5). Osteogenic differentiation determined by immunopositivity for 
osteopontin was not observed in the monolayer cultures, or in any NPgel culture 
conditions (Fig. 5). 
Immunohistochemical evaluation of matrix degrading enzymes within 
MSCs cultured in NPgel.  
To assess hMSCs matrix degrading enzyme production within MSCs cultured within 
NPgel in the presence of cytokines and free Ca2+, immunohistochemistry was 
performed to assess the expression of matrix metalloproteinases (MMPs 3, 13, and 
ADAMTs 4) (Fig. 6). The percentage of cells immunopositive for MMP3 and MMP13 
was significantly increased in all the cultures with 2.5mM and 5mM CaCl2 compared 
to the non-degenerate standard control (MMP 3: 2.5mM CaCl2 P=0.0005; 5mM 
CaCl2 P=0.0005; MMP 13: 2.5mM CaCl2 P=0.0094; 5mM CaCl2 P<0.0001) and 
percentage of cells immunopositive for ADAMTS 4 was significantly increased 
following culture with 5mM CaCl2 (P=0.0004)(Fig. 6). The co-stimulation with 
cytokines had no further influence on the percentage of cells which displayed 
immunohistochemistry for MMPs or ADAMTs (Fig. 6).  
A
cc
ep
te
d 
A
rti
cl
e
This article is protected by copyright. All rights reserved.
14 
 
Immunohistochemical evaluation of catabolic mediators in the presence 
of cytokines and free Ca2+. 
Immunocytochemistry was performed to assess the expression of known catabolic 
mediator: IL-1 and its receptor IL-1RI in monolayer cultures and following 
embedding into hydrogel alone and following culture in CaCl2. The percentage 
immunopositivity for endogenous IL-1 and its receptor (IL-1RI) were decreased 
under non-degenerate standard culture conditions following embedding into the 
hydrogel, in comparison to the monolayer controls (IL-1P=0.0216; IL-1RI: 
P=0.0014) (Fig. 7). Whilst the percentage of cells immunopositive for endogenous IL-
1 significantly increased when cultured with 2.5mM CaCl2 and 5mM CaCl2 
compared to standard hydrogel cultures and IL-1RI increased following culture in 
hydrogels with 5mM CaCl2 (IL-12.5mM CaCl2 P=0.0003; 5mM CaCl2 P=0.0001; IL-
1RI: 5mM CaCl2 P=0.0052)(Fig. 7).  
Discussion 
We have previously reported a synthetic Laponite® crosslinked pNIPAM-co-DMAc 
(NPgel) hydrogel, which induces nucleus pulposus (NP) cell differentiation of human 
MSCs (hMSCs) without the need for additional growth factors45. This differentiation 
in the absence of growth factors is likely to be due to the highly hydrated nature of 
the hydrogel, together with similar mechanical properties and O2 concentration to 
native NP tissue which appears to provide the appropriate cues supporting 
differentiation. Furthermore NP gel supports integration following injection into the 
disc and restores mechanical function to the disc44. This system provides a potential 
regenerative approach for the degenerate IVD, however successful translation is 
dependent on cellular behaviour within the degenerate niche which a hostile 
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catabolic environment. Thus, here, we investigated the viability and differentiation of 
hMSCs within the L-pNIPAM-co-DMAc hydrogel (NPgel) within a hostile catabolic 
microenvironment associated with degeneration28-36, a 4 week timepoint was 
selected as this has been shown previously to be suffient to support MSC 
differentation within NPgel towards NP like cells45. These studies aimed to determine, 
whether combination therapies to inhibit the degenerate niche would be necessary to 
improve the likelihood of success for MSC applications. Thus, highlighting the 
importance of identifying clinical targets based on severity of degeneration which 
could have key implications for successful treatment outcomes.  
The metabolic activity of hMSCs incorporated within NPgel was maintained 
throughout all the degenerate culture conditions. However, proliferation was not 
evident, possibly due to a focus on cellular differentiation, or structural limitations of 
the three dimensional hydrogel construct. We have previously reported this 
phenomenon and an associated reduction in pore size as a result of matrix 
deposition within the hydrogel in vitro45. Here, within this study, 
immunohistochemical analysis of the apoptotic marker caspase 3, showed increased 
levels of apoptosis of the differentiated hMSCs in the presence of multiple cytokines 
and/or calcium, although at low levels (≤20% apoptotic) compared to the non-
degenerate standard culture model, suggesting the degenerate niche may induce 
apoptosis to low levels. This agrees with previous studies where native NP cells 
within the degenerate disc have been shown to display increased levels of apoptosis 
14 and senescence15-18. However the clinical implication of these low levels of 
apoptosis is likely to be minimal.  
In agreement with previous findings, this study demonstrated that hMSCs 
incorporated into NPgel and cultured under hypoxic non-degenerate conditions in 
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vitro, induces differentiation of hMSCs into NP-like cells without the need for 
additional growth factors45. Here, we have shown that MSCs incorporated into NPgel, 
cultured within a hypoxic, non-catabolic environment (i.e. in the absence of cytokines 
and calcium), produced NP matrix components: collagen type II, aggrecan and NP 
markers. Unfortunately due to the non-degradable nature of the hydrogel it is not 
possible to perform quantitative biochemical analysis or gene expression analysis on 
these systems and immunohistochemistry was deployed to investigate changes in 
cellular expression of proteins. Interestingly, hMSCs also expressed NP matrix 
components collagen type II and aggrecan even in the presence of the cytokines and 
free Ca2+. The ability of hydrogel encapsulated hMSCs to differentiate into NP like 
cells capable of producing NP like matrix components even in the presence of 
cytokines and free Ca2+ is extremely promising as a treatment strategy for 
regeneration of the IVD.  
Previous studies have shown that NP cells upregulate the expression of MMP3, 
MMP13 and ADAMTS 4 in response to treatment with IL-1 & TNF33, 47-49. Here, 
where hMSCs were treated with IL-1 or TNF alone, or in combination, no 
significant difference in immunopositivity was observed for MMP3, MMP13 and 
ADAMTS 4. Interestingly, studies have shown that MSCs in monolayer display an 
increase in MMP expression in response to cytokines50, 51, whilst this was not seen in 
hMSCs cultured within NPgel. Studies have shown that 3D culture systems are 
advantageous for stem cell differentiation, increase therapeutic potential and 
enhance anti-inflammatory properties of MSCs52, 53. Here, we have shown that 
hMSC expression of endogenous IL-1 and IL-1RI was decreased where MSCs 
were incorporated into hydrogel when compared to the monolayer controls. The 
exact mechanism by which NPgel induces these protective roles is not clear but 
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could be due to the similar mechanical properties to native normal NP disc and 
culture within a hydrated 3D system. Our combination therapy therefore exhibits an 
advantageous mechanism over other proposed therapies43 within the catabolic 
degenerate disc, further work is required to determine the exact cellular mechanism 
for the protective effects seen here.  
When Ca2+ was present within the degenerate culture conditions, a significant 
increase in calcium deposition was observed in MSC-laden NPgel cultures 
compared to the acellular controls. This has also been observed in isolated disc cells 
and healthy caudal IVDs cultured in the presence of increased Ca2+ 36. Furthermore, 
an increase in the expression of collagen type I, MMP3, MMP13 and ADAMTS 4 was 
observed. MMP13 has been previously shown to be increased in chondrocytes in 
response to accumulated calcium phosphate crystals in osteoarthritis54. This could 
suggest that calcium treatment and subsequent deposition alters the phenotype and 
differentiation of hMSCs, possibly to a more accelerated degenerate phenotype. 
MSCs have also previously been shown to undergo osteogenic differentiation in the 
presence of Ca2+55, 56 and here, we observed an increase in collagen type I that 
could indicate possible osteogenic differentiation, although osteopontin was not 
induced. This could have an impact on the ability of hMSCs to regenerate 
appropriate mechanically functional matrix and so poses the question, in disc 
degeneration where calcification is present, will the differentiation of MSCs be 
altered adversely. Importantly, this could have key implications for treatment during 
late stage degeneration where calcification is often observed36, 57, 58.  
The next stages will be to recapitulate the other features seen within the degenerate 
niche, including decreased osmolality, pH, nutrients and mechanical load to fully 
understand how the mesenchymal stem cells delivered via NPgel will behave within 
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the degenerate disc. Furthermore the work reported in this paper has been 
performed on commercially derived MSCs which are limited by patient variation and 
thus it is essential to investigate the behaviour of patient stem cells within the 
hydrogel to determine patient variation within the NPgel system.  
Conclusion 
MSCs embedded within Laponite® crosslinked pNIPAM-co-DMAc hydrogel (NPgel) 
and cultured under conditions to simulate the degenerate niche (cytokines and 
calcium) retained their differentiation ability, expressing aggrecan and collagen type 
II. However, calcium treatments increased expression of degradation enzymes and 
inappropriate matrix components, highlighting the potential role of calcium in 
degeneration and the importance to consider the severity and stage of disc 
degeneration when targeting such a therapy. Importantly, the Laponite® crosslinked 
pNIPAM-co-DMAc hydrogel described here, not only has the potential to provide 
mechanical support and deliver MSCs for regeneration of the IVD, but also may 
simultaneously function to protect delivered MSCs from the catabolic environment in 
degeneration. 
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Table 1: Immunohistochemistry methodology and antibody details. 
  
Target 
Antibody 
Catalogue 
Number (Abcam, 
Cambridge, UK) 
Clonality Optimal 
Dilution 
Antigen 
Retrieva
l 
Secondary 
Antibody 
Serum 
Block 
Caspase 3 
 
ab13847 Rabbit 
Polyclonal 
1:400 None Goat anti 
rabbit 
Goat 
Aggrecan ab3778 Mouse 
Monoclon
al 
1:100 Heat Rabbit anti 
mouse 
Rabbit  
Collagen 
type II 
ab34712 Rabbit 
Polyclonal 
1:200 Enzyme Goat anti 
rabbit 
Goat  
Collagen 
type I 
ab90395 Mouse 
Monoclon
al 
1:200 Enzyme Rabbit anti 
mouse 
Rabbit  
FOXF1 
 
ab23194 Rabbit 
Polyclonal 
1:100 Heat Goat anti 
rabbit 
Goat 
PAX1 
 
ab203065 Rabbit 
Polyclonal 
1:400 Enzyme Goat anti 
rabbit 
Goat 
HIF1α 
 
ab16066 Mouse 
monoclon
al 
1:100 None Rabbit anti 
mouse 
Rabbit 
MMP3 ab53015 Rabbit 
Polyclonal 
1:400 Enzyme Goat anti 
rabbit 
Goat 
  
MMP13 ab39012 Rabbit 
Polyclonal 
1:200 Heat Goat anti 
rabbit 
Goat 
 
ADAMTS 4 ab185722 Rabbit 
polyclonal 
1:200 None Goat anti 
rabbit 
Goat 
 
IL-1β ab53732 Rabbit 
Polyclonal 
1:100 Heat Goat anti 
rabbit 
Goat 
 
IL-1RI ab106278 Rabbit 
Polyclonal 
1:100 Enzyme Goat anti 
rabbit 
Goat 
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Figure Legends:  
Figure 1: Immunohistochemical assessment of apoptotic marker caspase 3 in 
hMSCs cultured in monolayer (A) and acellular NPgel controls (B) and in hMSCs 
embedded in NPgel following culture for 4 weeks in 5% O2 under non-degenerate 
(C) and degenerate culture conditions (5.0mM CaCl2 + IL1β + TNFα) (D). Black 
arrows indicate positively stained cells and white arrows indicate negatively stained 
cells. Scale bar 100μm. Inlet shows magnified image of individual cells. (E) 
Percentage immunopositivity was calculated and statistical analysis performed * 
indicates significant difference between percentage immunopositivity following CaCl2 
treatment compared to standard media controls, # indicates significant difference 
following treatment with IL-1β,  indicates significant difference following treatment 
with TNFα, ^ indicates significant difference following treatment with IL-1 β and TNFα 
(p ≤ 0.05).  
Figure 2: Histological (Alcian Blue and Masson Trichrome) and 
immunohistochemical assessment (Aggrecan, collagen type II and collagen type I) of 
hMSCs and acellular controls following culture for 4 weeks in NPgel cultured under 
5% O2 under non-degenerate and degenerate culture conditions (5.0mM CaCl2 + 
IL1β + TNFα), together with monolayer controls. Black arrows indicate positively 
stained cells and white arrows indicate negatively stained cells. Scale bar 100μm. 
Inlet shows magnified image of individual cells.  
Figure 3: Percentage immunopositive cells for aggrecan, collagen type II and 
collagen type I within hMSCs cultured in monolayer hMSCs cultured in NPgel. 
Statistical analysis performed * indicates significant difference between percentage 
immunopositivity following CaCl2 treatment compared to standard media controls, # 
indicates significant difference following treatment with IL-1β,  indicates significant 
difference following treatment with TNFα, ^ indicates significant difference following 
treatment with IL-1 β and TNFα (p ≤ 0.05).  
Figure 4: Co-localisation of calcium deposition within hMSCs laden NPgels and 
acellular controls following culture for 4 weeks under non degenerate (standard 
culture media) and degenerate (2.5mM and 5.0mM CaCl2) culture conditions. A: 
Histological stains: Alizarin red for calcium deposition. Scale bar 100μm. B: ImageJ 
percentage matrix staining for calcium deposition. Statistical analysis performed * 
indicates significant difference between percentage immunopositivity following CaCl2 
treatment compared to standard media controls, # indicates significant difference 
following treatment with IL-1β,  indicates significant difference following treatment 
with TNFα, ^ indicates significant difference following treatment with IL-1 β and TNFα 
(p ≤ 0.05). 
Figure 5: A: Immunohistochemical detection of NP phenotypic markers: FOXF1, 
PAX1 and HIF-1α, and NP negative marker: osteopontin in hMSCs in monolayer 
culture and resuspended in NPgel and acellular controls following culture for 4 
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weeks in 5% O2 under non degenerate and degenerate culture condition (5.0mM 
CaCl2 + IL1β + TNFα). Scale bar 100μm. Inlet shows magnified image of individual 
cells. B: Percentage immunopositivity was calculated statistical analysis performed * 
indicates significant difference between percentage immunopositivity following CaCl2 
treatment compared to standard media controls, # indicates significant difference 
following treatment with IL-1β,  indicates significant difference following treatment 
with TNFα, ^ indicates significant difference following treatment with IL-1 β and TNFα 
(p ≤ 0.05). 
Figure 6: A: Immunohistochemical detection of matrix turnover markers: MMP3, 
MMP13 and ADAMTS4 in hMSCs encapsulated in NPgel cultured under non-
degenerate (standard media control) and degenerate conditions (5.0mM CaCl2, ± 
IL1β + TNFα) for 4 weeks. Black arrows indicate positively stained cells and white 
arrows indicate negatively stained cells. Scale bar 100μm. Inlet shows magnified 
image of individual cells. B: Percentage immunopositivity was calculated and 
statistical analysis performed * indicates significant difference between percentage 
immunopositivity following CaCl2 treatment compared to standard media controls, # 
indicates significant difference following treatment with IL-1β,  indicates significant 
difference following treatment with TNFα, ^ indicates significant difference following 
treatment with IL-1 β and TNFα (p ≤ 0.05). 
Figure 7: A: Immunohistochemical detection of IL-1β and its receptor IL-1RI. 
immunohistochemical staining prior to hydrogel incorporation (0hrs) (monolayer 
control) and after 4 weeks following NPgel incorporation, cultured under non-
degenerate (standard media control) and in the presence of 2.5 mM CaCl2 or 5.0mM 
CaCl2. Black arrows indicate positively stained cells and white arrows indicate 
negatively stained cells. Scale bar 100μm. Inlet shows magnified image of individual 
cells. B: Percentage immunopositivity was calculated and statistical analysis 
performed to investigate change from monolayer controls to NPgel culture and 
hMSCs within NPgel following CaCl2 treatment compared to standard media controls 
(* = p ≤ 0.05). 
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